Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New program aims to help young latino cancer survivors speak up with family and doctors

NCT ID NCT07606443

First seen Jun 02, 2026 · Last updated Jun 20, 2026 · Updated 6 times

Summary

This study tests a new program to help Hispanic/Latino young adults who survived childhood cancer communicate better with their family and doctors. The program involves a community health worker who meets with the survivor and a support person before and after a clinic visit. The study is very small (18 people) and only checks if the program is feasible and acceptable, not if it improves health.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHILDHOOD CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Stanford University

    Palo Alto, California, 94304, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Family-centered communication intervention (behavioral)

What this could lead to

If it works, this could point toward a practical way to improve communication and support for young cancer survivors and their families.

What could go wrong

This is a very small, early feasibility study with only 18 participants. It is not designed to prove the intervention works, only that it can be delivered and is acceptable.

Conditions

The condition(s) this trial relates to.

childhood malignant neoplasm neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.